Global Kidney Stone Management Devices Market to Reach $1.6 Billion by 2027

Kidney stones can develop in either one or both of the kidneys. According to the National Health Service, it can afflict persons between the ages of 30 and 60. (NHS). According to the NHS, three out of every twenty males and two out of every twenty women in the world suffer from kidney stones each year. According to the National Health and Nutrition Examination Survey (NHANES) published in 2012, kidney stones were present in 10.6% of men and 7.1 percent of women.


Despite the COVID-19 controversy, the global market for Kidney Stone Management Devices, which was anticipated to be worth US$1.3 billion in 2020, is expected to increase to US$1.6 billion by 2027, with a CAGR of 3% throughout the analysis period. Extracorporeal Shock Wave Lithotripsy, one of the report's segments, is expected to grow at a 1.1 percent CAGR over the next five years, reaching US$522.3 million by the conclusion of the study period. Following an early assessment of the pandemic's business effects and the resulting economic crisis, the Percutaneous Nephrolithotomy segment's growth is revised to a revised 3.4 percent CAGR for the following seven years.

The market in the United States is estimated to be worth $346.5 million, while China is expected to grow at a rate of 5.2 percent each year.

The market for Kidney Stone Management Devices in the United States is expected to reach US$346.5 million by 2020. China, the world's second largest economy, is expected to reach a projected market size of US$313.1 million by 2027, representing a 5.2 percent CAGR from 2020 to 2027. Japan and Canada are two more important geographic markets, with forecasted growth rates of 0.9 percent and 2.1 percent, respectively, from 2020 to 2027. Germany is expected to expand at a CAGR of around 1.4 percent in Europe.





Intracorporeal Lithotripsy Segment to Record 4.4% CAGR

The United States, Canada, Japan, China, and Europe are expected to fuel the global Intracorporeal Lithotripsy segment's 3.8 percent CAGR. By the end of the analysis period, these regional markets, which had a combined market value of US$350.2 million in 2020, will have grown to US$455.6 million. China will remain among the fastest-growing in this cluster of regional markets. The Asia-Pacific market is expected to reach US$219.1 million by 2027, led by countries like Australia, India, and South Korea, while Latin America will grow at a 5.4 percent CAGR during the same period.

Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

YOU YES YOU!

Lack of alternative treatments for epiphora medical disorders is a key restraint on the Nasal Lacrimal Stent Market